David Ian Johnson, President and CEO at Alliqua BioMedical, Inc. (ALQA), bought 10,000 shares at $4.65 ($47K) on 2015-05-27, disclosed to the SEC on 2015-05-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |